List of Excipients in API OCTREOTIDE ACETATE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing OCTREOTIDE ACETATE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation | SANDOSTATIN | octreotide acetate | 0078-0180 | LACTIC ACID | |
| Novartis Pharmaceuticals Corporation | SANDOSTATIN | octreotide acetate | 0078-0180 | MANNITOL | |
| Novartis Pharmaceuticals Corporation | SANDOSTATIN | octreotide acetate | 0078-0180 | SODIUM BICARBONATE | |
| Novartis Pharmaceuticals Corporation | SANDOSTATIN | octreotide acetate | 0078-0180 | WATER | |
| Sun Pharmaceutical Industries Inc | BYNFEZIA PEN | octreotide acetate | 62756-452 | LACTIC ACID | |
| Sun Pharmaceutical Industries Inc | BYNFEZIA PEN | octreotide acetate | 62756-452 | MANNITOL | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing OCTREOTIDE ACETATE
Detailed excipient profiles for OCTREOTIDE ACETATE
Excipient focus: ACETIC ACID
OCTREOTIDE ACETATE drug variants containing ACETIC ACID
OCTREOTIDE ACETATE drug variants not containing ACETIC ACID
Excipient focus: LACTIC ACID
OCTREOTIDE ACETATE drug variants containing LACTIC ACID
OCTREOTIDE ACETATE drug variants not containing LACTIC ACID
Excipient focus: LACTIC ACID, L-
OCTREOTIDE ACETATE drug variants containing LACTIC ACID, L-
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
| Mylan Institutional LLC | octreotide acetate | 67457-239 |
| >Company | >Ingredient | >NDC |
OCTREOTIDE ACETATE drug variants not containing LACTIC ACID, L-
Excipient focus: MANNITOL
OCTREOTIDE ACETATE drug variants containing MANNITOL
OCTREOTIDE ACETATE drug variants not containing MANNITOL
Excipient focus: PHENOL
OCTREOTIDE ACETATE drug variants containing PHENOL
OCTREOTIDE ACETATE drug variants not containing PHENOL
Excipient focus: SODIUM ACETATE
OCTREOTIDE ACETATE drug variants containing SODIUM ACETATE
OCTREOTIDE ACETATE drug variants not containing SODIUM ACETATE
Excipient focus: SODIUM BICARBONATE
OCTREOTIDE ACETATE drug variants containing SODIUM BICARBONATE
OCTREOTIDE ACETATE drug variants not containing SODIUM BICARBONATE
Excipient focus: SODIUM CHLORIDE
OCTREOTIDE ACETATE drug variants containing SODIUM CHLORIDE
OCTREOTIDE ACETATE drug variants not containing SODIUM CHLORIDE
Excipient focus: SODIUM HYDROXIDE
OCTREOTIDE ACETATE drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | octreotide acetate | 0641-6174 |
| Mylan Institutional LLC | octreotide acetate | 67457-239 |
| >Company | >Ingredient | >NDC |
OCTREOTIDE ACETATE drug variants not containing SODIUM HYDROXIDE
Excipient focus: WATER
OCTREOTIDE ACETATE drug variants containing WATER
OCTREOTIDE ACETATE drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Fresenius Kabi USA LLC | octreotide acetate | 63323-365 |
| Fresenius Kabi USA LLC | octreotide acetate | 63323-377 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
